2002 Milestones
Oral Heparin: PROTECT Phase III data top line results in Q202
Oral LMW Heparin: Initiate Phase I testing
Oral Insulin: Initiate 90-day toxicology studies
Oral Insulin: Initiate fed/fasted Type II patient study
Oral PTH: Complete Phase I trial
Oral rhGH: Phase I initiation pending
Oral Cromolyn: Preliminary patient studies in allergy patients